Health-related quality of life during a phase 2 study of talazoparib in patients with advanced breast cancer and germline BRCA1/2 mutations (ABRAZO).
Hurvitz, S Turner, N Telli, M Rugo, H Mailliez, A Ettl, J Grischke, E Mina, L BalmaƱa, J Fasching, P
Hurvitz, S
Turner, N
Telli, M
Rugo, H
Mailliez, A
Ettl, J
Grischke, E
Mina, L
BalmaƱa, J
Fasching, P
Citations
Altmetric:
Abstract
Description
Date
2018-02-14
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Health-related quality of life during a phase 2 study of talazoparib in patients with advanced breast cancer and germline BRCA1/2 mutations (ABRAZO). 2018, 78(4 Suppl): P5-19-05 Cancer Res